LNTH Stock — Lantheus Holdings Inc.

Lantheus Holdings Inc. (LNTH)

Updated October 16, 2026.

LNTH is a Stock. Total return is 1561.7% over the past 11.3 years, 1225.7 points ahead of SPY at 336.0%.

Lantheus Holdings develops, manufactures, and commercializes diagnostic and therapeutic products for imaging and treating heart disease, cancer, and other conditions. The company's portfolio includes diagnostic agents such as DEFINITY for echocardiography and PYLARIFY for prostate cancer imaging, along with therapeutic products like RELISTOR and pipeline candidates in radiopharmaceutical therapy. The distribution status is not currently known.

LNTH performance versus SPY

Price and return data through 2026-10-16.

Total return is 1561.7% over the past 11.3 years, 1225.7 points ahead of SPY at 336.0%. Over the past year its total return — price change plus distributions reinvested — is 76.9%. Its deepest 1-year drawdown was 12.8%.

LNTH key facts

Asset type

Stock

Asset class

Equity

Inception date

06/24/2015

Distribution frequency

None

Last close

$99.70 (as of 2026-10-16)

Market cap

$6,510,397,538

Average volume

1711569.0

Beta

-0.058

Payout ratio

0.0%

P/E ratio

24.14

Forward P/E

14.2653

EPS

$4.13

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

LNTH risks and drawbacks

The deepest 1-year drawdown on record here is 12.8%.

Who may consider LNTH — and who may not

It is a weaker fit for investors who need monthly cash flow (LNTH does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on LNTH

• All tickers starting with L

Tagged: Pharmaceutical.

Frequently asked questions